Similar articles for PMID: 27754905

Year	Number of Results
1996	1
2002	1
2006	1
2007	1
2009	3
2010	3
2011	1
2012	4
2013	5
2014	5
2015	11
2016	33
2017	31
2018	18
2019	12
2020	20
2021	18
2022	19
2023	10
2024	0

1

Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.

Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, Tilly H, Vera P, Meignan MA, Becker S. Cottereau AS, et al. J Nucl Med. 2017 Feb;58(2):276-281. doi: 10.2967/jnumed.116.180406. Epub 2016 Oct 6. J Nucl Med. 2017. PMID: 27754905 Free article.

2

Prognostic value of metabolic tumour volume on baseline ¹⁸F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Shagera QA, Cheon GJ, Koh Y, Yoo MY, Kang KW, Lee DS, Kim EE, Yoon SS, Chung JK. Shagera QA, et al. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1417-1427. doi: 10.1007/s00259-019-04309-4. Epub 2019 Apr 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30941463

3

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Decazes P, Becker S, Toledano MN, Vera P, Desbordes P, Jardin F, Tilly H, Gardin I. Decazes P, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1672-1679. doi: 10.1007/s00259-018-4041-0. Epub 2018 Apr 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29705879

4

Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.

Feng X, Wen X, Li L, Sun Z, Li X, Zhang L, Wu J, Fu X, Wang X, Yu H, Ma X, Zhang X, Xie X, Han X, Zhang M. Feng X, et al. Cancer Res Treat. 2021 Jul;53(3):837-846. doi: 10.4143/crt.2020.123. Epub 2020 Dec 2. Cancer Res Treat. 2021. PMID: 33285054 Free PMC article.

5

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.

Cottereau AS, Lanic H, Mareschal S, Meignan M, Vera P, Tilly H, Jardin F, Becker S. Cottereau AS, et al. Clin Cancer Res. 2016 Aug 1;22(15):3801-9. doi: 10.1158/1078-0432.CCR-15-2825. Epub 2016 Mar 2. Clin Cancer Res. 2016. PMID: 26936916

6

Prognostic Values of Baseline ¹⁸F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma.

Zhou Y, Zhang X, Qin H, Zhao Z, Li J, Zhang B, Sang S, Wu Y, Deng S. Zhou Y, et al. Biomed Res Int. 2020 Feb 25;2020:9746716. doi: 10.1155/2020/9746716. eCollection 2020. Biomed Res Int. 2020. PMID: 32185229 Free PMC article.

7

Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients.

Cottereau AS, El-Galaly TC, Becker S, Broussais F, Petersen LJ, Bonnet C, Prior JO, Tilly H, Hutchings M, Casasnovas O, Meignan M. Cottereau AS, et al. J Nucl Med. 2018 Apr;59(4):589-595. doi: 10.2967/jnumed.117.193946. Epub 2017 Sep 1. J Nucl Med. 2018. PMID: 28864629 Free article.

8

Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.

Schmitz C, Rekowski J, Müller SP, Hertenstein B, Franzius C, Ganser A, Bengel FM, Kroschinsky F, Kotzerke J, La Rosée P, Freesmeyer M, Hoeffkes HG, Hertel A, Behringer D, Mesters R, Weckesser M, Mahlmann S, Haberkorn U, Martens U, Prange-Krex G, Brenner W, Giagounidis A, Moeller R, Runde V, Sandmann M, Hautzel H, Wilop S, Krohn T, Dürk H, Heike M, Alashkar F, Brinkmann M, Trenn G, Wacker D, Kreisel-Büstgens C, Bernhard H, Heil G, Larisch R, Kurch L, Jöckel KH, Hoelzer D, Klapper W, Boellaard R, Dührsen U, Hüttmann A. Schmitz C, et al. Hematol Oncol. 2020 Aug;38(3):244-256. doi: 10.1002/hon.2697. Epub 2020 Feb 18. Hematol Oncol. 2020. PMID: 32067259

9

Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma.

Liang JH, Zhang YP, Xia J, Ding CY, Wu W, Wang L, Cao L, Zhu HY, Fan L, Li TN, Li JY, Xu W. Liang JH, et al. Cancer Res Treat. 2019 Oct;51(4):1479-1487. doi: 10.4143/crt.2018.649. Epub 2019 Mar 12. Cancer Res Treat. 2019. PMID: 30913868 Free PMC article.

10

Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma.

Lue KH, Chen YH, Wu YF, Liu SH. Lue KH, et al. Nucl Med Commun. 2023 Jan 1;44(1):74-80. doi: 10.1097/MNM.0000000000001640. Epub 2022 Nov 15. Nucl Med Commun. 2023. PMID: 36514929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

155 results

Results by year